The Association between Resolvin D1 Levels and Gestational Diabetes Mellitus: Implications for Perinatal Outcomes

OBJECTIVE: To evaluate maternal Resolvin D1 levels in women with gestational diabetes mellitus (GDM) and investigate the association between perinatal outcomes. STUDY DESIGN: This case-control study included 88 singleton pregnancies, conducted from August 2023 to January 2024, at a tertiary care...

Full description

Saved in:
Bibliographic Details
Main Authors: Zeynep Seyhanli, Burak Bayraktar, Mevlut Bucak, Gulsan Karabay, Betul Tokgoz Cakir, Can Ozan Ulusoy, Gizem Aktemur, Selver Ozge Sefik, Serap Topkara Sucu, Sevki Celen, Ali Turhan Caglar
Format: Article
Language:English
Published: Medical Network 2024-08-01
Series:Gynecology Obstetrics & Reproductive Medicine
Subjects:
Online Access:https://gorm.com.tr/index.php/GORM/article/view/1505
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823857326774288384
author Zeynep Seyhanli
Burak Bayraktar
Mevlut Bucak
Gulsan Karabay
Betul Tokgoz Cakir
Can Ozan Ulusoy
Gizem Aktemur
Selver Ozge Sefik
Serap Topkara Sucu
Sevki Celen
Ali Turhan Caglar
author_facet Zeynep Seyhanli
Burak Bayraktar
Mevlut Bucak
Gulsan Karabay
Betul Tokgoz Cakir
Can Ozan Ulusoy
Gizem Aktemur
Selver Ozge Sefik
Serap Topkara Sucu
Sevki Celen
Ali Turhan Caglar
author_sort Zeynep Seyhanli
collection DOAJ
description OBJECTIVE: To evaluate maternal Resolvin D1 levels in women with gestational diabetes mellitus (GDM) and investigate the association between perinatal outcomes. STUDY DESIGN: This case-control study included 88 singleton pregnancies, conducted from August 2023 to January 2024, at a tertiary care center. Participants were divided into two groups: 44 pregnant women diagnosed with GDM comprised the study group, and 44 healthy pregnant women served as the control group. Additionally, the GDM group was categorized based on management approach into 21 women managed with diet alone and 23 women requiring insulin therapy. Maternal plasma Resolvin D1 levels and maternal-neonatal outcomes were then compared between groups. The analysis involved determining the optimal Resolvin D1 cut-off levels for predicting composite adverse neonatal outcomes in GDM using receiver operating characteristic curve (ROC) analysis. RESULTS: The plasma Resolvin D1 level in pregnant women with GDM was significantly higher compared to the control group (337±74.1 vs. 297±56.7, p<0.001). Furthermore, maternal plasma Resolvin D1 levels were associated with composite adverse neonatal outcomes [presence of at least one of the following conditions: preterm birth (<37 weeks), low birth weight (LBW) (<2500 grams), neonatal hypoglycemia, hyperbilirubinemia, APGAR score at 5th minute <7, respiratory distress syndrome (RDS), and admission to the neonatal intensive care unit (NICU)], with a cut-off of >338.75, showing a sensitivity of 56.3%, a specificity of 79.2%, and an AUC of 0.675 (95% CI: 0.567-0.771, p=0.024). CONCLUSIONS: This study demonstrated that pregnancies affected by GDM exhibit elevated levels of Resolvin D1, which is associated with a higher incidence of composite adverse neonatal outcomes.
format Article
id doaj-art-0d77b6a7aa20451d885c365c04e9701d
institution Kabale University
issn 1300-4751
2602-4918
language English
publishDate 2024-08-01
publisher Medical Network
record_format Article
series Gynecology Obstetrics & Reproductive Medicine
spelling doaj-art-0d77b6a7aa20451d885c365c04e9701d2025-02-11T21:18:37ZengMedical NetworkGynecology Obstetrics & Reproductive Medicine1300-47512602-49182024-08-0130210.21613/GORM.2023.1505The Association between Resolvin D1 Levels and Gestational Diabetes Mellitus: Implications for Perinatal OutcomesZeynep Seyhanli0Burak Bayraktar1Mevlut Bucak2Gulsan Karabay3Betul Tokgoz Cakir4Can Ozan Ulusoy5Gizem Aktemur6Selver Ozge Sefik7Serap Topkara Sucu8Sevki Celen9Ali Turhan Caglar10Ankara Etlik City HospitalDepartment of Perinatology, Ankara Etlik City Hospital, Ankara /TurkiyeDepartment of Perinatology, Ankara Etlik City Hospital, Ankara /TurkiyeDepartment of Perinatology, Ankara Etlik City Hospital, Ankara /TurkiyeDepartment of Perinatology, Ankara Etlik City Hospital, Ankara /TurkiyeDepartment of Perinatology, Ankara Etlik City Hospital, Ankara /TurkiyeDepartment of Perinatology, Ankara Etlik City Hospital, Ankara /TurkiyeDepartment of Obstetrics and Gynecology, Ankara Etlik City Hospital, Ankara /TurkiyeDepartment of Obstetrics and Gynecology, Ankara Etlik City Hospital, Ankara /TurkiyeDepartment of Perinatology, Ankara Etlik City Hospital, Ankara /TurkiyeDepartment of Perinatology, Ankara Etlik City Hospital, Ankara /Turkiye OBJECTIVE: To evaluate maternal Resolvin D1 levels in women with gestational diabetes mellitus (GDM) and investigate the association between perinatal outcomes. STUDY DESIGN: This case-control study included 88 singleton pregnancies, conducted from August 2023 to January 2024, at a tertiary care center. Participants were divided into two groups: 44 pregnant women diagnosed with GDM comprised the study group, and 44 healthy pregnant women served as the control group. Additionally, the GDM group was categorized based on management approach into 21 women managed with diet alone and 23 women requiring insulin therapy. Maternal plasma Resolvin D1 levels and maternal-neonatal outcomes were then compared between groups. The analysis involved determining the optimal Resolvin D1 cut-off levels for predicting composite adverse neonatal outcomes in GDM using receiver operating characteristic curve (ROC) analysis. RESULTS: The plasma Resolvin D1 level in pregnant women with GDM was significantly higher compared to the control group (337±74.1 vs. 297±56.7, p<0.001). Furthermore, maternal plasma Resolvin D1 levels were associated with composite adverse neonatal outcomes [presence of at least one of the following conditions: preterm birth (<37 weeks), low birth weight (LBW) (<2500 grams), neonatal hypoglycemia, hyperbilirubinemia, APGAR score at 5th minute <7, respiratory distress syndrome (RDS), and admission to the neonatal intensive care unit (NICU)], with a cut-off of >338.75, showing a sensitivity of 56.3%, a specificity of 79.2%, and an AUC of 0.675 (95% CI: 0.567-0.771, p=0.024). CONCLUSIONS: This study demonstrated that pregnancies affected by GDM exhibit elevated levels of Resolvin D1, which is associated with a higher incidence of composite adverse neonatal outcomes. https://gorm.com.tr/index.php/GORM/article/view/1505Resolvin D1gestational diabetes mellitusperinatal outcomes
spellingShingle Zeynep Seyhanli
Burak Bayraktar
Mevlut Bucak
Gulsan Karabay
Betul Tokgoz Cakir
Can Ozan Ulusoy
Gizem Aktemur
Selver Ozge Sefik
Serap Topkara Sucu
Sevki Celen
Ali Turhan Caglar
The Association between Resolvin D1 Levels and Gestational Diabetes Mellitus: Implications for Perinatal Outcomes
Gynecology Obstetrics & Reproductive Medicine
Resolvin D1
gestational diabetes mellitus
perinatal outcomes
title The Association between Resolvin D1 Levels and Gestational Diabetes Mellitus: Implications for Perinatal Outcomes
title_full The Association between Resolvin D1 Levels and Gestational Diabetes Mellitus: Implications for Perinatal Outcomes
title_fullStr The Association between Resolvin D1 Levels and Gestational Diabetes Mellitus: Implications for Perinatal Outcomes
title_full_unstemmed The Association between Resolvin D1 Levels and Gestational Diabetes Mellitus: Implications for Perinatal Outcomes
title_short The Association between Resolvin D1 Levels and Gestational Diabetes Mellitus: Implications for Perinatal Outcomes
title_sort association between resolvin d1 levels and gestational diabetes mellitus implications for perinatal outcomes
topic Resolvin D1
gestational diabetes mellitus
perinatal outcomes
url https://gorm.com.tr/index.php/GORM/article/view/1505
work_keys_str_mv AT zeynepseyhanli theassociationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT burakbayraktar theassociationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT mevlutbucak theassociationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT gulsankarabay theassociationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT betultokgozcakir theassociationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT canozanulusoy theassociationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT gizemaktemur theassociationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT selverozgesefik theassociationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT seraptopkarasucu theassociationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT sevkicelen theassociationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT aliturhancaglar theassociationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT zeynepseyhanli associationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT burakbayraktar associationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT mevlutbucak associationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT gulsankarabay associationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT betultokgozcakir associationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT canozanulusoy associationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT gizemaktemur associationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT selverozgesefik associationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT seraptopkarasucu associationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT sevkicelen associationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes
AT aliturhancaglar associationbetweenresolvind1levelsandgestationaldiabetesmellitusimplicationsforperinataloutcomes